16-1241307-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003294.4(TPSAB1):ā€‹c.216A>Gā€‹(p.Ala72Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0644 in 94,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.064 ( 0 hom., cov: 35)
Exomes š‘“: 0.14 ( 4 hom. )
Failed GnomAD Quality Control

Consequence

TPSAB1
NM_003294.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -11.8
Variant links:
Genes affected
TPSAB1 (HGNC:12019): (tryptase alpha/beta 1) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, alpha and beta 1. Beta tryptases appear to be the main isoenzymes expressed in mast cells; whereas in basophils, alpha tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 16-1241307-A-G is Benign according to our data. Variant chr16-1241307-A-G is described in ClinVar as [Benign]. Clinvar id is 1244990.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-11.8 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TPSAB1NM_003294.4 linkc.216A>G p.Ala72Ala synonymous_variant 3/6 ENST00000338844.8 NP_003285.2 Q15661-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TPSAB1ENST00000338844.8 linkc.216A>G p.Ala72Ala synonymous_variant 3/61 NM_003294.4 ENSP00000343577.3 Q15661-1

Frequencies

GnomAD3 genomes
AF:
0.0644
AC:
6088
AN:
94504
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0317
Gnomad AMI
AF:
0.100
Gnomad AMR
AF:
0.0519
Gnomad ASJ
AF:
0.0550
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.0791
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.0857
Gnomad NFE
AF:
0.0744
Gnomad OTH
AF:
0.0629
GnomAD3 exomes
AF:
0.0444
AC:
6872
AN:
154736
Hom.:
1
AF XY:
0.0446
AC XY:
3707
AN XY:
83178
show subpopulations
Gnomad AFR exome
AF:
0.0116
Gnomad AMR exome
AF:
0.0274
Gnomad ASJ exome
AF:
0.0545
Gnomad EAS exome
AF:
0.0433
Gnomad SAS exome
AF:
0.0546
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.0443
Gnomad OTH exome
AF:
0.0374
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.143
AC:
112556
AN:
785852
Hom.:
4
Cov.:
154
AF XY:
0.137
AC XY:
53676
AN XY:
393028
show subpopulations
Gnomad4 AFR exome
AF:
0.0560
Gnomad4 AMR exome
AF:
0.0445
Gnomad4 ASJ exome
AF:
0.0766
Gnomad4 EAS exome
AF:
0.0836
Gnomad4 SAS exome
AF:
0.0829
Gnomad4 FIN exome
AF:
0.0920
Gnomad4 NFE exome
AF:
0.163
Gnomad4 OTH exome
AF:
0.119
GnomAD4 genome
AF:
0.0644
AC:
6089
AN:
94578
Hom.:
0
Cov.:
35
AF XY:
0.0659
AC XY:
3054
AN XY:
46352
show subpopulations
Gnomad4 AFR
AF:
0.0317
Gnomad4 AMR
AF:
0.0520
Gnomad4 ASJ
AF:
0.0550
Gnomad4 EAS
AF:
0.152
Gnomad4 SAS
AF:
0.0795
Gnomad4 FIN
AF:
0.144
Gnomad4 NFE
AF:
0.0744
Gnomad4 OTH
AF:
0.0634
Alfa
AF:
0.0891
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMay 05, 2021- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.41
DANN
Benign
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201568970; hg19: chr16-1291308; COSMIC: COSV58779749; API